Manipal Health Enterprises is making its stock market debut today, August 5, 2026, with analysts widely anticipating a subdued listing. The healthcare service provider, which operates a vast network of multi-specialty hospitals, clinics, and diagnostic centers across India, saw its shares offered in a price band of Rs 560-590 apiece.
The initial public offering (IPO) aimed to raise Rs 9,275 crore, with subscriptions running from July 29 to July 31. Despite improving market sentiments, the grey market premium (GMP) for Manipal Health shares saw a sharp correction ahead of the listing. It was last reported at Rs 3-5 per share, indicating a largely flat listing for investors, a significant drop from the Rs 10 GMP observed during the bidding period.
Analyst Expectations Point to Flat-to-Discount Listing
Market experts have largely maintained a cautious outlook on the Manipal Health IPO. Mahesh M. Ojha, VP of Research at Kantilal Chagganlal Securities, highlighted several factors contributing to the muted expectations, including rich valuations, subdued operating metrics, limited growth use of IPO proceeds, and a weak subscription trend, particularly the under-subscription in the retail investor category.
"We expect the listing performance to remain muted, with the possibility of a flat-to-discount listing," Ojha stated. He advised allotted investors to consider booking profits on any meaningful listing gains and suggested fresh investors wait for 1-2 quarters for better visibility on earnings growth and operational improvements before considering an entry.
Similarly, Prasenjit Paul, Fund Manager at 129 Wealth and Head of Research at Paul Asset, echoed these sentiments. "We continue to expect a muted listing for Manipal Health IPO. Investors seeking listing gains may find the risk-reward unfavourable at the issue price," Paul commented, though he noted that long-term investors with a two-to-three-year horizon might monitor execution triggers.
IPO Details and Company Profile
The Manipal Health Enterprises IPO was subscribed nearly 4.92 times overall, attracting approximately 3.60 lakh applications totaling over Rs 26,000 crore in bids. The qualified-institutional bidders (QIBs) portion was subscribed 8.25 times, while non-institutional investors (NIIs) and employee quotas were booked 1.02 times and 2.19 times, respectively. Notably, the retail portion was under-subscribed at just 93 percent.
Incorporated in 2010 and headquartered in Bengaluru, Manipal Health Enterprises is a prominent healthcare service provider in India. It offers a comprehensive range of services, including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare.
Kotak Mahindra Capital, Axis Capital, Goldman Sachs (India) Securities, Jefferies India, JP Morgan India, UBS Securities India, and DBS Bank served as the book-running lead managers for the IPO. Kfin Technologies Ltd was the registrar for the issue. Manipal Health shares will be listed on both BSE Ltd and NSE.